Euronext N.V Company Profile

06:42 EST 12th December 2018 | BioPortfolio

Euronext N.V., a holding company incorporated under Dutch law that operates through local subsidiaries, was formed on 22 September 2000 when the exchanges of Amsterdam, Brussels and Paris merged. The Euronext group expanded at the beginning of 2002 with the acquisition of LIFFE (London International Financial Futures and Options Exchange) and the merger with the Portuguese exchange BVLP (Bolsa de Valores de Lisboa e Porto). Today, Euronext is Europe’s leading cross-border exchange, integrating trading and clearing operations on regulated and non-regulated markets for cash products and derivatives. Euronext was formed in 2000 in response to the globalisation of capital markets and to create a pan-European exchange offering its participants increased liquidity and lower transaction costs.


Cannon Bridge House1 Cousin Lane
United Kingdom


Phone: 44 20 7623 0444

News Articles [121 Associated News Articles listed on BioPortfolio]

Erytech Pharma S.A.: Monatliche Information bezüglich der Gesamtzahl der Stimmrechte und der Aktien, die das Aktienkapital bilden - 31. August 2018

Artikel 223-16 der allgemeinen Verordnung der französischen Autorité des Marchés FinanciersLyon - Frankreich Notiert an folgenden Märkten: Euronext Paris von Euronext (Marktsegment B - ISIN-Code: ...

Erytech Pharma S.A.: Monthly information related to total number of voting rights and shares composing the share capital - October 31, 2018

LYON, France, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Article 223-16 of general regulation of French Autorité des Marchés FinanciersLyon - France Listing markets: Euronext Paris from Euronext DateTotal o....

Pharnext SA completes €31mm IPO on Euronext Alternext Stock Exchange

In its initial public offering on the Euronext Alternext Stock Exchange, Pharnext SA (drug repositioning) raised €31mm ($34.2mm) through the sale of 2.9mm shares (2.6mm shares issued as part of a gl...

Inventiva raises €48m in Euronext IPO

Advicenne raised a €27m IPO on Euronext Paris

Euronext-listed Argenx plans €68.6m IPO in the US

Oxurion NV Announces New NYSE Euronext Brussels Stock Ticker "OXUR" and Launch of New Websit

Oxurion NV trading under "OXUR" on NYSE Euronext Brussels Oxurion NV launches new global website showcasing its comprehensive drug development approach and diverse portfolio of next-generation ...

Natgasoline Successfully Places Around $900 Million of New Debt at More Attractive Terms Than ...

BEAUMONT, Texas, November 2, 2018 /PRNewswire/ -- Consolidated Energy Limited ("CEL") and OCI N.V. (Euronext: OCI) have today announced that their subsidiary Natgasoline LLC, the Read more...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [57 Associated Companies listed on BioPortfolio]

Euronext N.V

Euronext N.V., a holding company incorporated under Dutch law that operates through local subsidiaries, was formed on 22 September 2000 when the exchanges of Amsterdam, Brussels and Paris merged. The ...

NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trad...

Nutreco Holding N.V.

Nutreco Holding N.V. is an international company in the animal nutrition and fish feed markets, where it seeks to create added value through its knowledge of the food chains. The company has a selecte...


Gemalto (Euronext NL 0000400653 GTO) is the world leader in digital security with 2009 annual revenues of €1.65 billion, and over 10,000 employees operating out of 75 offices...

Galapagos nv

Galapagos was founded in 1999 as a joint venture between Crucell (formerly IntroGene) and Tibotec. From the start, Galapagos has operated a hybrid business model, combining internal discovery programs...

More Information about "Euronext N.V" on BioPortfolio

We have published hundreds of Euronext N.V news stories on BioPortfolio along with dozens of Euronext N.V Clinical Trials and PubMed Articles about Euronext N.V for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Euronext N.V Companies in our database. You can also find out about relevant Euronext N.V Drugs and Medications on this site too.

Quick Search


Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Corporate Database Quicklinks

Searches Linking to this Company Record